Pappo, A S <br/><br/>
A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma.  [electronic resource] 

 -  Journal of pediatric hematology/oncology   
 - 438-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1077-4114 
<br/><br/><label>Standard No.: </label>10.1097/00043426-199709000-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Methotrexate--adverse effects<br/>Neoplasm Staging<br/>Radiography<br/>Rhabdomyosarcoma--diagnostic imaging<br/>Risk Assessment<br/>Survival Rate